学院（School）:

The First School of Medicine

专业（Discipline）:

Thyorid Surgery

研究方向（Research Interests）:

1. The precision diagnosis of thyroid tumors

2. The comprehensive treatment of anaplastic thyroid cancer

邮箱（Email）:

cyfoncology@wmu.edu.cn

个人简历（Biography）

教育背景(Educational Background)

2008/09 - 2013/06: Bachelor's Degree in Clinical Medicine, Wenzhou Medical University

2013/09 - 2016/06: Master's Degree in Oncology, Wenzhou Medical University

2021/09 - 2024/06: Ph.D. in Integrated Traditional Chinese and Western Medicine, Zhejiang Chinese Medical University

工作经历(Working Experience)

2016/08 - 2021/12: Resident Physician, Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University

2021/12 - Present: Attending Physician, Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University

学术兼职(Part-time Academic Jobs)

1. Committee Member, Thyroid Professional Committee of Zhejiang Cancer Minimally Invasive Surgery Alliance

2. Youth Expert, Health Head and Neck Thyroid Surgery Science Popularization Database of Zhejiang Provincial Health Commission

3. Mentor, Zhejiang Province High School Students Talent Program

4. Youth Committee Member, Breast Cancer Professional Committee of Wenzhou Anti-Cancer Association

所获荣誉(Awards)

1. Second Prize, Zhejiang Provincial Medical and Health Science and Technology Award for Omics Research in Thyroid Cancer

2. Third Prize, Tumor Minimally Invasive Video Elite Competition (Thyroid Group)

3. Outstanding Researcher, The First Affiliated Hospital of Wenzhou Medical University

4. Outstanding Employee (2020, 2024), The First Affiliated Hospital of Wenzhou Medical University

5. Outstanding Communist Party Member (2024), The First Affiliated Hospital of Wenzhou Medical University

6. Anti-epidemic Hero, The First Affiliated Hospital of Wenzhou Medical University

发表文章（Representative Publication）

1.Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway, Phytomedicine，2022 (Co-first author， IF=6.656)

2.The association between dietary selenium intake and Hashimoto’s thyroiditis among US adults: National Health and Nutrition Examination Survey (NHANES) ，Journal of Endocrinological Investigation，2022. (Co-first author，IF=5.467)

3. A Novel and Effective Model to Predict Skip Metastasis in Papillary Thyroid Carcinoma Based on a Support Vector Machine. Frontiers in Endocrinology.2022.(2区, IF=6.055)，Corresponding author

4. Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case-control study. Cancer Management and Research.2018.(3区, IF=3.602) Corresponding author

5. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study. Cancer Management and Research. 2018.(3区, IF=3.602) Corresponding author

6. A scoring system is an effective tool for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a case-control study. World Journal of Surgical Oncology. 2016.(3区, IF=3.253) First author

7. A panel of four genes accurately differentiates benign from malignant thyroid nodules. J Exp Clin Cancer Res.2016.(1区, IF=12.658) Co-first author

8. The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study. Medicine. 2015.(4区, IF=1.817) First author

9. A Case Report: The Diagnosis and Therapeutic Evaluation for a Rare Disease of Langerhans Cell Histiocytosis Involving Thyroid. Medicine. 2015.(4区, IF=1.817) First author

10.Correlation of Cystatin E/M with Clinicopathological Features and Prognosis in Triple-Negative Breast Cancer. Ann Clin Lab Sci. 2018.(4区, IF=1.180) Corresponding author